Identification of novel antagonist toxins of T-type calcium channel for analgesic purposes
US8664179B2 · kind B2 · utility
0Cited by
2References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 15, 2010 |
| Grant date | Mar 4, 2014 |
| Priority date | — |
| Expiry date | Jan 15, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A peptide with the following sequence YCQKFLWTCDSERPCCEGLVCRLWCKIN (SEQ ID NO 1) or a derivative thereof, and nucleic acids coding for the peptide having the sequence (SEQ ID NO 1). Also the use of this peptide as an antagonist and/or reverse agonist of T-type calcium channels. A use of the peptide for preparing a drug, in particular an analgesic one.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.